<table border="single" id="id_04bdf77a-5b28-417e-8472-681476c8cdf8" width="478" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_2b7817c6-803f-4356-a9c2-411d83f66640"> Table 11: Results of Drug Interaction Studies with Buffered Formulations of Didanosine:                  Effects of Coadministered Drug of Didanosine Plasma AUC and C<sub>max </sub>Values</caption>
<col width="34.5%"></col>
<col width="24.7%"></col>
<col width="8.4%"></col>
<col width="16.5%"></col>
<col width="15.9%"></col>
<tbody>
<tr id="id_a6c34d20-c799-48d3-a7e8-ecaaeffd335a">
<td align="left" colspan="3" stylecode="Toprule" valign="top"></td>
<td align="center" colspan="2" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">% Change of Didanosine</content>
</paragraph>
<content stylecode="bold">Pharmacokinetic Parameters<footnote id="id-f8c070db-4efe-4f6b-bdb1-67a82d345280">The 95% confidence intervals for the percent change in the pharmacokinetic parameter are displayed.</footnote>
</content>
</td>
</tr>
<tr id="id_4b54b938-cff8-469c-a7f1-dddad8ca5fba">
<td align="center" colspan="3" stylecode="Botrule" valign="top">
<content stylecode="bold">         Drug                                      Didanosine Dosage                       n        </content>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">AUC of Didanosine</content>
</paragraph>
<content stylecode="bold">(95% CI)</content>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>
<content stylecode="bold">C<sub>max</sub> of Didanosine</content>
</paragraph>
<content stylecode="bold">(95% CI)</content>
</td>
</tr>
<tr id="id_881a41ef-de1a-423f-a596-47e170850f9d">
<td align="left" stylecode="Botrule" valign="top">
<paragraph>allopurinol,</paragraph>
<paragraph>renally impaired, 300 mg/day</paragraph>
<paragraph>healthy volunteer, 300 mg/day</paragraph>
<paragraph>for 7 days</paragraph>
<paragraph>ganciclovir, 1000 mg every <br/>8 hours, 2 hours after didanosine</paragraph>
<paragraph>ciprofloxacin, 750 mg every <br/>12 hours for 3 days, 2 hours before </paragraph>
<paragraph>didanosine</paragraph>
<paragraph>indinavir, 800 mg single dose</paragraph>
<paragraph>   simultaneous</paragraph>
<paragraph>   1 hour before didanosine</paragraph>
<paragraph>ketoconazole, 200 mg/day for <br/>4 days, 2 hours before didanosine</paragraph>
<paragraph>loperamide, 4 mg every 6 hours for 1 day</paragraph>
<paragraph>metoclopramide, 10 mg single dose</paragraph>
<paragraph>ranitidine, 150 mg single dose, <br/>2 hours before didanosine</paragraph>
<paragraph>rifabutin, 300 or 600 mg/day for <br/>12 days</paragraph>
<paragraph>ritonavir, 600 mg every 12 hours for 4 days</paragraph>
<paragraph>stavudine, 40 mg every 12 hours for 4 days</paragraph>
<paragraph>sulfamethoxazole, 1000 mg single dose</paragraph>
<paragraph>trimethoprim, 200 mg single dose</paragraph>
zidovudine, 200 mg every 8 hours for 3 days</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>200 mg single dose</paragraph>
<paragraph>400 mg single dose</paragraph>
<paragraph>200 mg every</paragraph>
<paragraph>12 hours</paragraph>
<paragraph>200 mg every</paragraph>
<paragraph>12 hours for 3 days</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>375 mg every</paragraph>
<paragraph>12 hours for 4 days</paragraph>
<paragraph>300 mg single dose</paragraph>
<paragraph>300 mg single dose</paragraph>
<paragraph>375 mg single dose</paragraph>
<paragraph>167 or 250 mg every</paragraph>
<paragraph>12 hours for 12 days</paragraph>
<paragraph>200 mg every</paragraph>
<paragraph>12 hours for 4 days</paragraph>
<paragraph>100 mg every</paragraph>
<paragraph>12 hours for 4 days</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>200 mg single dose</paragraph>
<paragraph>200 mg every</paragraph>
12 hours for 3 days</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>2</paragraph>
<paragraph>14</paragraph>
<paragraph>12</paragraph>
<paragraph>8<footnote id="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5">HIV-infected patients.</footnote>
</paragraph>
<paragraph>16</paragraph>
<paragraph>16</paragraph>
<paragraph>12<footnoteref idref="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5"></footnoteref>
</paragraph>
<paragraph>12 <footnoteref idref="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5"></footnoteref>
</paragraph>
<paragraph>12<footnoteref idref="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5"></footnoteref>
</paragraph>
<paragraph>12<footnoteref idref="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5"></footnoteref>
</paragraph>
<paragraph>11</paragraph>
<paragraph>12</paragraph>
<paragraph>10</paragraph>
<paragraph>8<footnoteref idref="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5"></footnoteref>
</paragraph>
<paragraph>8 <footnoteref idref="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5"></footnoteref>
</paragraph>
6<footnoteref idref="id-c7f759fe-9760-4d17-a0f0-ac21413c40e5"></footnoteref>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 312%</paragraph>
<paragraph>↑ 113%</paragraph>
<paragraph>↑ 111%</paragraph>
<paragraph>↓ 16%</paragraph>
<paragraph>↔</paragraph>
<paragraph>↓ 17%</paragraph>
<paragraph>(-27, -7%)<footnote id="id-b18f6db0-91d2-4eef-a11f-fc2c9d95f931">90% CI.</footnote>
</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↑ 14%</paragraph>
<paragraph>↑ 13%</paragraph>
<paragraph>(-1, 27%)</paragraph>
<paragraph>↓ 13%</paragraph>
<paragraph>(0, 23%)</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
</td>
<td align="center" stylecode="Botrule" valign="top">
<paragraph>↑ 232%</paragraph>
<paragraph>↑ 69%</paragraph>
<paragraph>NA</paragraph>
<paragraph>↓ 28%</paragraph>
<paragraph>↔</paragraph>
<paragraph>↓ 13%</paragraph>
<paragraph>(-28, 5%)<footnoteref idref="id-b18f6db0-91d2-4eef-a11f-fc2c9d95f931"></footnoteref>
</paragraph>
<paragraph>↓ 12%</paragraph>
<paragraph>↓ 23%</paragraph>
<paragraph>↑ 13%</paragraph>
<paragraph>↑ 13%</paragraph>
<paragraph>↑ 17%</paragraph>
<paragraph>(-4, 38%)</paragraph>
<paragraph>↓ 16%</paragraph>
<paragraph>(5, 26%)</paragraph>
<paragraph>↔</paragraph>
<paragraph>↔</paragraph>
<paragraph>↑ 17%</paragraph>
<paragraph>(-23, 77%)</paragraph>
<paragraph>↔</paragraph>
</td>
</tr>
</tbody>
</table>